Journal
BMC GENOMICS
Volume 12, Issue -, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/1471-2164-12-36
Keywords
-
Funding
- European Union [LSHM-CT2005-018652]
- Italian Association for Cancer Research [IG-8586]
- Italian Ministry for Education, University and Research [PRIN 2008CJ4SYW_004]
- Fondazione per il Sud [2009-PdP-22]
- Direct For Biological Sciences
- Div Of Biological Infrastructure [0923513] Funding Source: National Science Foundation
Ask authors/readers for more resources
Background: Estrogen receptors alpha (ER alpha) and beta (ER beta) are transcription factors ( TFs) that mediate estrogen signaling and define the hormone-responsive phenotype of breast cancer (BC). The two receptors can be found co-expressed and play specific, often opposite, roles, with ER beta being able to modulate the effects of ER alpha on gene transcription and cell proliferation. ER beta is frequently lost in BC, where its presence generally correlates with a better prognosis of the disease. The identification of the genomic targets of ER beta in hormone-responsive BC cells is thus a critical step to elucidate the roles of this receptor in estrogen signaling and tumor cell biology. Results: Expression of full-length ER beta in hormone-responsive, ER alpha-positive MCF-7 cells resulted in a marked reduction in cell proliferation in response to estrogen and marked effects on the cell transcriptome. By ChIP-Seq we identified 9702 ER beta and 6024 ER alpha binding sites in estrogen-stimulated cells, comprising sites occupied by either ER beta, ER alpha or both ER subtypes. A search for TF binding matrices revealed that the majority of the binding sites identified comprise one or more Estrogen Response Element and the remaining show binding matrixes for other TFs known to mediate ER interaction with chromatin by tethering, including AP2, E2F and SP1. Of 921 genes differentially regulated by estrogen in ER beta+ vs ER beta-cells, 424 showed one or more ER beta site within 10 kb. These putative primary ER beta target genes control cell proliferation, death, differentiation, motility and adhesion, signal transduction and transcription, key cellular processes that might explain the biological and clinical phenotype of tumors expressing this ER subtype. ER beta binding in close proximity of several miRNA genes and in the mitochondrial genome, suggests the possible involvement of this receptor in small non-coding RNA biogenesis and mitochondrial genome functions. Conclusions: Results indicate that the vast majority of the genomic targets of ER beta can bind also ER alpha, suggesting that the overall action of ER beta on the genome of hormone-responsive BC cells depends mainly on the relative concentration of both ERs in the cell.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available